NP632743.RAcLBxgeTGxTnpKYmjq uDxo0s-5qrP42-JvI8fJ-cKpw
type: Nanopublication
has assertion: NP632743.RAcLBxgeTGxTnpKYmjq uDxo0s-5qrP42-JvI8fJ-cKpw130 assertion
has provenance: NP632743.RAcLBxgeTGxTnpKYmjq uDxo0s-5qrP42-JvI8fJ-cKpw130 provenance
has publication info: NP632743.RAcLBxgeTGxTnpKYmjq uDxo0s-5qrP42-JvI8fJ-cKpw130 publicationInfo
created: 2014-10-02T12:38:22+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetrdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v2.1.0.0

NP632743.RAcLBxgeTGxTnpKYmjq uDxo0s-5qrP42-JvI8fJ-cKpw130 assertion
type: Assertion
description: [It may be possible to determine the appropriate CY dose in the preconditioning regimen for SCT in FA patients on the basis of the in vitro effects on fragility, and Flu or Ara-C may be a safer drug than high-dose CY for conditioning in FA patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/17483082
was generated by: ECO_0000203

befree-20140225
imported on: 2014-02-25

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetrdf
version: v2.1.0